Fleming Europe 3rd Annual Pharma Packaging and Labelling Conference, 19-20 March, Berlin

Fleming Europe 3rd Annual Pharma Packaging and Labelling Conference, 19-20 March, Berlin

Last week I attended and spoke at the Fleming Europe 3rd Annual Pharma Packaging and Labelling Conference in Berlin.  There were a number of excellent presentations from a range of speakers.

Present 1 – The implementation of anti-counterfeiting features in Pharma Packaging material.  

Pilar Pena, Quality Assurance Manager, Nekicesa Packaging, Spain.

Pilar gave an interesting presentation of the range of anti-counterfeiting and tamper evident solutions available and how they can be combined with serialisation solutions to meet the EU requirements for 2017.  This led to a lively debate on when companies need to start preparing to meet the requirements.

Present 2 – Implementation of the European Medicines Verification System (EMVS).  

Hans-Walter Hoehl, VP Strategy and Projects, Global Pharmaceutical Production, Bayer Healthcare Product Supply, Germany

Hans-Walter presented on the work that EFPIA and the European Stakeholder Alliance are doing to meet the challenges of falsified medicines in Europe.  He also outlined emerging legislative requirements in other countries around the world.

Present 3 – Benefits of the implementation of GS1 Standards.  

Ulrike Kreysa, VP Healthcare, GS1 Global Office, Belgium

Ulrike gave a presentation on the latest that GS1 is doing to facilitate the provision of standard coding approaches to ensure complexity in coding systems is minimised.  She also discussed work undertaken by McKinsey on the benefits to patient safety and cost performance than can be achieved from standardisation.

Present 4 – Can we use Barcodes on Medication Packaging to improve Patient Safety and increase Supply Chain Efficiency?  

Feargal McGroarty, Project Manager, National Haemophilia System. St James’s Hospital,  Ireland

Feargal presented on how barcodes can improve hospital operations and in particular focussed on a distribution scheme implemented in Ireland to support supply of blood products to haemophiliacs.  This system uses authentication through the supply chain to ensure the right patient gets the right product and complies with regime.  This is a highly beneficial capability that has been introduced, providing great patient safety benefit

Present 5 – Serialisation and beyond.  

John McKeon, Technical Director, Portalis Limited. Ireland

John’s present looked at the equipment level impacts of serialisation and some of the considerations that are required to ensure the right capabilities are installed in the factory.  John also talked about where we should be looking beyond merely complying with the legislation, to drive the maximum value from the technology for enhanced patient safety and supply chain management.

Present 6 – India 2013: Insights into Serialisation.  

Rajesh Mishra, GM Packaging Development, Abbott, India

The requirements, timelines and potential solutions for serialisation in India were covered by Rajesh’s presentation.  Rajesh spoke about the Indian healthcare environment and the need to address counterfeiting.  He covered the emerging legislative environment and how GS1 is helping provide standards.  He also discussed many of the challenges being faced by companies in meeting the legislation.

Present 7 – Packaging design with focus on patient adherence.  

Hinrik Petursson, Global Artwork Director, Actavis, Switzerland

Hinrick presented on the benefits and opportunities good packaging and graphic design can have on patient compliance.  Simple solutions and good layouts of graphics can have great impacts on the usability and compliance of the product.  Increasing the adherence will have a significant impact on the end patient.

Present 8 – Seeking for effective methods to improve patient compliance and adherence.  

Tassilo Korab, Executive Director, Healthcare Compliance Packaging Council, Austria.

In this presentation, Tassilo covered the reasons for poor patient compliance and how packaging design can help, particularly with accessibility and clear provision of information.  From studies undertaken by HCPC, the benefits of clearly marked blister calendar packs was clear to see as was easy to open closures.

Tassilo also shared some good and not so good examples of packaging designs to illustrate the impacts on elderly patients.

Present 9 – Implementing new Technologies and Information Management to achieve efficiency in Packaging Operations.  

Carolina Sanchez Cespedes, Manager of Packaging Operations, Eli Lilly, Spain

Carolina presented on the impacts on packaging facilities from all of the different legislative and commercial drivers that exist.  She outlined the activities that are being undertaken at her factory to increase flexibility and responsiveness.

Present 10 – Better Information, Better Health!  Reading and Understanding Information about Medicines.  

Karel van der Waarde, Professor, Avans, University of Applied Sciences, Breda, The Netherlands

In Karel’s present he covered the implications of poor provision of information to users.  The design, layout and presentation of information are important to aid understanding and compliance, as is the language structure and clarity of instruction.

Karel highlighted how it can be challenging to comply with legislation whilst also providing simple and concise instruction to patients.

Present 11 – Quality Management in an Artwork Studio.  

Suzanne Ivory, Quality Manager, The Perogord Group, Ireland.

Suzanne presented on the need for an effective quality management system in your artwork studio.  She outlined the different elements of a quality management system and the capabilities required to implement and operate. She also discussed the procedures required to operate a compliant and controlled artwork studio and the measures you can put in place to ensure the required performance is achieved.

Present 12 – Developing and Sustaining Excellent Packaging Labelling and Artwork Capabilities.  

Andrew Love, VP Capability Development, Be4ward Ltd

I presented on the capabilities a Pharma company needs to consider to ensure it has a sustainable end-to-end artwork and labelling service.  To view the presentation please click here: Berlin 2013_Developing and Sustaining Excellent Packaging Labelling and Artwork Capabilities V2_0

Present 13 – Tamper Evidence and Unique Codes in the War against Counterfeiting.

Dr. Marietta Ulrich-Horn, CEO, Securikett, Austria

Marietta presented on the different types of tamper evidence labels available and the requirements to be considered for unique identification coding systems and gateways.

Present 14 – Enforcement of the Falsified Medicines Directive at European legislative level.  

Jim Thompson, Chair, European Alliance for Safe Medicines, UK

Jim covered two main topics in his presentation – the latest on the implementation of the Falsified Medicines Regulations and work that EAASM is doing in partnership with other organisations to address the issue of illegitimate on-line pharmacies.  It was clear from the presentation that on-line pharmacies are a phenomenon that will continue, so the work being done is to ensure that legitimate on-line pharmacies can be clearly identified and illegitimate ones targeted.

Present 15 – US CPSC: New Regulation on Child-Resistant Packaging for certain Decongestants – Implications for Drug Manufacturers.  

Stephen Wilkins, Child-safe Packaging Group, UK

Finally, Stephen presented on the development and testing of child resistant packaging and the implications of such packaging on accessibility and elderly patients.  He included a number of ideas on how packaging could be improved to protect children whilst ensuring older patients could still access the medicines

Overall it was an excellent conference with many interesting and thought provoking topics.

No Comments

Post a Reply